Literature DB >> 19787726

First-pass and steady-state magnetic resonance angiography of the thoracic vasculature using gadofosveset trisodium.

Claas P Naehle1, Andreas Müller, Winfried A Willinek, Carsten Meyer, Tobias Hestermann, Juergen Gieseke, Hans Schild, Daniel Thomas.   

Abstract

PURPOSE: To compare a high-resolution, ECG-gated, motion-compensated, steady-state magnetic resonance angiography (SS-MRA) of the thoracic vasculature to standard first-pass MRA (FP-MRA) using a blood-pool contrast agent (gadofosveset trisodium).
MATERIALS AND METHODS: In all, 25 patients >or=18 years with congenital or acquired disease of the thoracic vasculature, who underwent both FP-MRA and SS-MRA, were retrospectively identified. Diameters of left superior pulmonary vein (LSPV), left pulmonary artery (LPA), and aortic arch (AA) were measured. Image quality for LSPV, LPA, AA, coronary ostia, and coronary sinus were assessed. Vessel sharpness of LPA and LSPV and contrast ratio (CR) of LSPV, LPA, and AA were calculated.
RESULTS: SS-MRA yielded significantly higher image quality for all vessels, and significantly higher vessel sharpness for LSPV and LPA compared to the FP-MRA. SS-MRA revealed lower intra- and interobserver variability for vessel diameters compared with the FP-MRA. The FP-MRA showed higher CR compared to the SS-MRA.
CONCLUSION: Motion-compensated high-resolution SS-MRA of the thoracic vasculature using gadofosveset trisodium offers superior image quality compared to standard FP-MRA. Although SS-MRA delivers no dynamic information it may prove specifically helpful as an add-on to FP-MRA for imaging of small vascular structures. (c) 2009 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19787726     DOI: 10.1002/jmri.21919

Source DB:  PubMed          Journal:  J Magn Reson Imaging        ISSN: 1053-1807            Impact factor:   4.813


  5 in total

1.  Dose response of the intravascular contrast agent gadofosveset trisodium in MR perfusion imaging of the myocardium using a quantitative evaluation.

Authors:  Sebastian Niedermayer; Steven Sourbron; Maria Prompona; Clemens Cyran; Maximilian Reiser; Armin Huber
Journal:  Int J Cardiovasc Imaging       Date:  2013-06-06       Impact factor: 2.357

2.  Improved quality and diagnostic confidence achieved by use of dose-reduced gadolinium blood-pool agents for time-resolved intracranial MR angiography.

Authors:  S Dehkharghani; J Kang; A M Saindane
Journal:  AJNR Am J Neuroradiol       Date:  2013-08-22       Impact factor: 3.825

3.  A comparison between gadofosveset trisodium and gadobenate dimeglumine for steady state MRA of the thoracic vasculature.

Authors:  G Paul Camren; Gregory J Wilson; Vikram R Bamra; Khahn Q Nguyen; Daniel S Hippe; Jeffrey H Maki
Journal:  Biomed Res Int       Date:  2014-06-29       Impact factor: 3.411

4.  Efficient non-contrast enhanced 3D Cartesian cardiovascular magnetic resonance angiography of the thoracic aorta in 3 min.

Authors:  Anastasia Fotaki; Camila Munoz; Yaso Emanuel; Alina Hua; Filippo Bosio; Karl P Kunze; Radhouene Neji; Pier Giorgio Masci; René M Botnar; Claudia Prieto
Journal:  J Cardiovasc Magn Reson       Date:  2022-01-10       Impact factor: 5.364

5.  High-resolution motion compensated MRA in patients with congenital heart disease using extracellular contrast agent at 3 Tesla.

Authors:  Darius Dabir; Claas Philip Naehle; Ralf Clauberg; Juergen Gieseke; Hans H Schild; Daniel Thomas
Journal:  J Cardiovasc Magn Reson       Date:  2012-10-29       Impact factor: 5.364

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.